Prostate cancer

Oncology

Current and future standard of care in prostate cancer

Despite recent advancements in the field of prostate cancer treatment, there remain distinct gaps in the current standard of care needing improvement.

Oncology

Prostate cancer awareness blue ribbon held by middle-aged man

The role of advanced imaging in transforming early detection...

The future of prostate cancer care lies in reimagining how we diagnose and monitor the disease.

News

Artera gets FDA okay for prostate cancer AI

A newly approved AI from Artera can guide treatment and predict prognosis in people diagnosed with localised prostate cancer.

Oncology

The impact of cancer on male sexual function

For many men, sex remains important throughout life – and that includes after a cancer diagnosis.

R&D

Trajectory-based diagnostics enable early intervention in pr...

Diagnostic testing in modern medicine remains largely episodic and threshold-based.

News

J&J bids to extend prostate cancer uses for Akeega

J&J is hoping the AMPLITUDE study results will make Akeega the first drug in the PARP inhibitor class for castration-sensitive prostate cancer.

Current and future standard of care in prostate cancer

The role of advanced imaging in transforming early detection...

Artera gets FDA okay for prostate cancer AI

The impact of cancer on male sexual function

Trajectory-based diagnostics enable early intervention in pr...

J&J bids to extend prostate cancer uses for Akeega

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

Prostate cancer

Editor's Picks